Apogee Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $24M | 600k | 39.73 |
| 2025-03-31 | $11M | 291k | 37.36 |
| 2024-12-31 | $19M | 408k | 45.30 |
| 2024-09-30 | $9.2M | 158k | 58.74 |
| 2024-06-30 | $13M | 337k | 39.35 |
| 2024-03-31 | $7.5M | 113k | 66.45 |
| 2023-12-31 | $775k | 28k | 27.94 |
| 2023-09-30 | $213k | 10k | 21.30 |